Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125614791 | 12561479 | 1 | I | 20160627 | 20160715 | 20160715 | PER | US-ELI_LILLY_AND_COMPANY-US201606010488 | ELI LILLY AND CO | 0.00 | M | Y | 0.00000 | 20160715 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125614791 | 12561479 | 1 | PS | TRULICITY | DULAGLUTIDE | 1 | Unknown | 0.75 MG, UNKNOWN | U | U | 125469 | .75 | MG | INJECTION | |||||
125614791 | 12561479 | 2 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 4 U, TID | U | U | 0 | 4 | IU | TID | |||||
125614791 | 12561479 | 3 | C | VICTOZA | LIRAGLUTIDE | 1 | Unknown | 0 | |||||||||||
125614791 | 12561479 | 4 | C | LANTUS | INSULIN GLARGINE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125614791 | 12561479 | 1 | Type 2 diabetes mellitus |
125614791 | 12561479 | 2 | Type 2 diabetes mellitus |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125614791 | 12561479 | Blood glucose increased | |
125614791 | 12561479 | Drug dose omission |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125614791 | 12561479 | 1 | 201605 | 0 | ||
125614791 | 12561479 | 2 | 201601 | 0 |